{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:00:57Z","timestamp":1753887657984,"version":"3.41.2"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"abstract":"<jats:p>The expansion of growth hormone therapy over the last 3 decades has allowed for treatment of short stature for more children, resulting in increased height for many. However, treatment of idiopathic short stature remains controversial. Treatment decisions for disabled children with idiopathic short stature are even more complicated. We discuss a specific case of short stature in a disabled child and grapple with the ethical issues involved in the use of growth hormone.<\/jats:p>","DOI":"10.1542\/peds.2017-3938","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T07:25:18Z","timestamp":1537428318000},"source":"Crossref","is-referenced-by-count":0,"title":["Growth Hormone Therapy for a Child With Severe Cognitive Impairment"],"prefix":"10.1542","volume":"142","author":[{"given":"Vincent E.","family":"Horne","sequence":"first","affiliation":[{"name":"Texas Children\u2019s Hospital and Department of Pediatrics, Baylor College of Medicine, Houston, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Gardner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Lantos","sequence":"additional","affiliation":[{"name":"Children\u2019s Mercy Hospital Kansas City, Kansas City, Missouri; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"issue":"7","key":"2021121023371882100_B1","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2009-2688","article-title":"Growth hormone and health policy.","volume":"95","author":"Cuttler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021121023371882100_B2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-1754.2012.02465.x","article-title":"Debate: idiopathic short stature should be treated with growth hormone.","volume":"49","author":"Ambler","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"10","key":"2021121023371882100_B3","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1210\/jc.2011-1739","article-title":"Clinical review: lessons learned from the hGH era.","volume":"96","author":"Allen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121023371882100_B4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000330145","article-title":"Psychological criteria for treating children with idiopathic short stature.","volume":"76","author":"Bullinger","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"2021121023371882100_B5","first-page":"1671","article-title":"Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.","volume":"77","author":"Amato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121023371882100_B6","doi-asserted-by":"crossref","first-page":"c7157","DOI":"10.1136\/bmj.c7157","article-title":"Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review.","volume":"342","author":"Deodati","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"2021121023371882100_B7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children.","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021121023371882100_B8","article-title":"Ethical issues related to the use of human growth hormone in idiopathic short stature.","volume":"11","author":"Preda","year":"2013","journal-title":"Rev Rom Bioet"},{"volume-title":"Classic Works in Medical Ethics: Core Philosophical Readings","year":"1998","author":"Pence","key":"2021121023371882100_B9"},{"issue":"7","key":"2021121023371882100_B10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00431-014-2480-6","article-title":"Understanding the impact of statural height on health-related quality of life in German adolescents: a population-based analysis.","volume":"174","author":"Sommer","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2021121023371882100_B11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1542\/peds.2009-3609","article-title":"A national study of physician recommendations to initiate and discontinue growth hormone for short stature.","volume":"126","author":"Silvers","year":"2010","journal-title":"Pediatrics"},{"issue":"13","key":"2021121023371882100_B12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMcp1213178","article-title":"Clinical practice. Short stature in childhood\u2013challenges and choices.","volume":"368","author":"Allen","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2021121023371882100_B13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2009.03775.x","article-title":"The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges.","volume":"72","author":"Savage","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2021121023371882100_B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0963180100903037","article-title":"Normal functioning and the treatment-enhancement distinction.","volume":"9","author":"Daniels","year":"2000","journal-title":"Camb Q Healthc Ethics"},{"issue":"1, pt 1","key":"2021121023371882100_B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(05)82438-2","article-title":"Growth hormone therapy for short stature: panacea or Pandora\u2019s box?","volume":"117","author":"Allen","year":"1990","journal-title":"J Pediatr"},{"issue":"4","key":"2021121023371882100_B16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.pcl.2015.04.009","article-title":"Short stature: is it a psychosocial problem and does changing height matter?","volume":"62","author":"Sandberg","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"2021121023371882100_B17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archpedi.156.3.230","article-title":"Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.","volume":"156","author":"Finkelstein","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"2021121023371882100_B18","first-page":"3653","article-title":"High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021121023371882100_B19","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1210\/jc.2016-2891","article-title":"Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature.","volume":"101","author":"Mauras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121023371882100_B20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121023371882100_B21","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, the Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.","volume":"97","author":"S\u00e4vendahl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021121023371882100_B22","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2021121023371882100_B23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000458526","article-title":"Growth promotion ethics and the challenge to resist cosmetic endocrinology.","volume":"87","author":"Allen","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"2021121023371882100_B24","doi-asserted-by":"crossref","first-page":"e20162526","DOI":"10.1542\/peds.2016-2526","article-title":"A push for progress with shared decision-making in pediatrics.","volume":"139","author":"Opel","year":"2017","journal-title":"Pediatrics"},{"issue":"8","key":"2021121023371882100_B25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.2010.1208","article-title":"The shared decision-making continuum.","volume":"304","author":"Kon","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"2021121023371882100_B26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency.","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2021121023371882100_B27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0272989X14546901","article-title":"An emerging field of research: challenges in pediatric decision making.","volume":"35","author":"Lipstein","year":"2015","journal-title":"Med Decis Making"},{"issue":"3","key":"2021121023371882100_B28","first-page":"129","article-title":"Perceived versus measured height. Which is the stronger predictor of psychosocial functioning?","volume":"53","author":"Hunt","year":"2000","journal-title":"Horm Res"},{"key":"2021121023371882100_B29","unstructured":"Rogol\u2008AD, Geffner\u2008ME, Hoppin\u2008AG. Growth hormone treatment for idiopathic short stature. 2017. Available at: https:\/\/www.uptodate.com\/contents\/growth-hormone-treatment-for-idiopathic-short-stature. Accessed July 15, 2018"},{"issue":"5","key":"2021121023371882100_B30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1542\/peds.2009-3649","article-title":"Variation in methods of predicting adult height for children with idiopathic short stature.","volume":"126","author":"Topor","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"2021121023371882100_B31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000346381","article-title":"Warning about warnings: weighing risk and benefit when information is in a state of flux.","volume":"79","author":"Laventhal","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"2021121023371882100_B32","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/MLR.0b013e31819e1f04","article-title":"Patient, physician, and consumer drivers: referrals for short stature and access to specialty drugs.","volume":"47","author":"Cuttler","year":"2009","journal-title":"Med Care"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3938\/1065464\/peds_20173938.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3938\/1065464\/peds_20173938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T08:03:48Z","timestamp":1639209828000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/142\/4\/e20173938\/37369\/Growth-Hormone-Therapy-for-a-Child-With-Severe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-3938","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"article-number":"e20173938"}}